Fundraising FoxBioGeneration Ventures — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Seattle, US
Meininger David(Executive Officer, Director, Promoter)
BoardRoger Ulrich(Director)Daniel O'Connell(Director)
Board seatEdward van Wezel· per SEC Form D · $17.3M raise · filed Apr 2021
Soteria Biotherapeutics develops protein-based biotherapeutics and small molecules using its LITE Switch technology platform for drug discovery and development across oncology, immune-oncology, and inflammatory disease indications.
BiotechDeep TechHealthtechMedical DevicesWellness & FitnessSan Francisco, US
Jim Wells(Co-founder, Scientific Advisory Board Chair)Kristine M Ball(Executive Officer, Director)inZachary Hill(Executive Officer, Director)in
BoardNisha Marathe(Director)David Allison(Director)inKeno Gutierrez(Director)in
Co-investors5AM VenturesNovartis Venture FundRoche Venture FundVersant VenturesWestlake Village BioPartners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Dunad Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.